Bleakley Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-3,934
| Closed | -$263K | – | 1086 |
|
2024
Q3 | $263K | Sell |
3,934
-907
| -19% | -$60.6K | 0.01% | 827 |
|
2024
Q2 | $575K | Buy |
4,841
+1,130
| +30% | +$134K | 0.02% | 564 |
|
2024
Q1 | $395K | Buy |
3,711
+362
| +11% | +$38.6K | 0.01% | 681 |
|
2023
Q4 | $333K | Sell |
3,349
-1,062
| -24% | -$106K | 0.01% | 704 |
|
2023
Q3 | $456K | Buy |
4,411
+497
| +13% | +$51.3K | 0.02% | 569 |
|
2023
Q2 | $476K | Sell |
3,914
-1,387
| -26% | -$169K | 0.01% | 601 |
|
2023
Q1 | $814K | Sell |
5,301
-317
| -6% | -$48.7K | 0.03% | 439 |
|
2022
Q4 | $1.01M | Buy |
+5,618
| New | +$1.01M | 0.04% | 371 |
|